Peter Carlin Sells 7,843 Shares of Adient (NYSE:ADNT) Stock

Adient (NYSE:ADNT) Director Peter Carlin sold 7,843 shares of the company’s stock in a transaction on Wednesday, September 2nd. The shares were sold at an average price of $19.25, for a total transaction of $150,977.75. Following the completion of the sale, the director owned 38,835 shares of the company’s stock, valued at approximately $747,573.75. This represents a 16.80% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Adient Price Performance

NYSE ADNT opened at $19.97 on Friday. The company has a debt-to-equity ratio of 1.18, a quick ratio of 0.91 and a current ratio of 1.10. The stock has a market cap of $1.54 billion, a price-to-earnings ratio of 33.28, a PEG ratio of 0.40 and a beta of 1.52. The business has a 50 day simple moving average of $19.65 and a 200 day simple moving average of $20.99. Adient has a 52-week low of $17.68 and a 52-week high of $27.32.

Adient (NYSE:ADNT) last issued its quarterly earnings results on Wednesday, August 5th. The company reported $0.48 EPS for the quarter, missing analysts’ consensus estimates of $0.56 by ($0.08). Adient had a net margin of 0.32% and a return on equity of 7.32%. The firm had revenue of $3.93 billion during the quarter, compared to the consensus estimate of $3.71 billion. During the same quarter last year, the firm earned $0.45 earnings per share. The business’s revenue for the quarter was up 4.3% on a year-over-year basis. Analysts anticipate that Adient will post 2.02 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Morgan Stanley dropped their price target on Adient from $22.00 to $21.00 and set an “equal weight” rating on the stock in a research note on Tuesday, August 18th. UBS Group reduced their target price on shares of Adient from $34.00 to $29.00 and set a “buy” rating for the company in a report on Thursday, August 6th. JPMorgan Chase & Co. boosted their price objective on Adient from $26.00 to $28.00 and gave the stock a “neutral” rating in a report on Monday, August 10th. Wall Street Zen downgraded Adient from a “buy” rating to a “hold” rating in a research report on Saturday, August 8th. Finally, Barclays lowered their target price on Adient from $29.00 to $25.00 and set an “equal weight” rating on the stock in a research note on Monday, August 10th. Six analysts have rated the stock with a Buy rating, three have given a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Adient currently has a consensus rating of “Hold” and an average target price of $26.60.

Institutional Trading of Adient

A number of institutional investors and hedge funds have recently bought and sold shares of ADNT. UBS Group AG raised its position in shares of Adient by 12.9% in the 4th quarter. UBS Group AG now owns 1,848,690 shares of the company’s stock worth $35,439,000 after acquiring an additional 210,758 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its stake in shares of Adient by 179.3% in the 1st quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 527,356 shares of the company’s stock valued at $10,658,000 after purchasing an additional 338,517 shares during the period. Principal Financial Group Inc. boosted its position in shares of Adient by 18.8% during the 1st quarter. Principal Financial Group Inc. now owns 448,624 shares of the company’s stock valued at $9,067,000 after purchasing an additional 71,055 shares in the last quarter. Segall Bryant & Hamill LLC bought a new stake in shares of Adient during the 1st quarter valued at about $1,404,000. Finally, SG Americas Securities LLC grew its stake in Adient by 117.8% during the first quarter. SG Americas Securities LLC now owns 913,585 shares of the company’s stock worth $18,464,000 after purchasing an additional 494,054 shares during the period. 92.44% of the stock is currently owned by institutional investors and hedge funds.

Adient Company Profile

Adient plc (NYSE: ADNT) is a leading global supplier of automotive seating and interior components. Established in 2016 through a spin-off from Johnson Controls, the company designs, engineers and manufactures complete seat assemblies, seat structures, mechanisms, foams, textiles, trim and electronics. Adient’s product portfolio spans a wide range of seating solutions, from entry-level designs to luxury and high-performance seats, and extends to interior modules such as door panels and center consoles.

Serving major original equipment manufacturers (OEMs) around the world, Adient works closely with automakers to develop lightweight, comfortable and safety-oriented seating systems.